EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Towards a risk classification for tumor lysis syndrome in solid neoplasms

José Grabiel Correa Rodríguez, Leonardo Manuel Castell Martínez, Nadia del Rosario Blanco Fiqueredo

SAP Health and Policy · 2026-07-24 · 5 · 326

DOI: 10.62486/shp2026326 ↗
AbstractBibliografische Angaben

Abstract

Introduction: Tumor lysis syndrome in solid tumors is a rare complication associated with high mortality. Its exclusion from clinical practice guideline risk classifications, as well as its underestimation, exacerbates this gap. Objective: To propose hypotheses for a risk classification model for tumor lysis syndrome in solid tumors. Development: Risk classification for tumor lysis syndrome in solid tumors should include three categories: high, intermediate, and low. In addition, there are factors that can increase the risk, such as metastatic burden, elevated lactate dehydrogenase levels, pre-existing renal and/or hepatic impairment, and disseminated intravascular coagulation. Conclusions: Although traditionally considered low-risk, tumor lysis syndrome in solid tumors should be addressed with classification models that allow for its appropriate stratification in daily clinical practice.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →